Target intelligence / Profile preview

microRNA let-7a (let-7a) (let-7a)

Target
let-7a
Molecular classification
microRNA, Non-coding RNA, Gene regulator
01

Overview

microRNA let-7a is a highly conserved, small non-coding RNA molecule that serves as a master regulator of gene expression by binding to the 3' untranslated regions (UTRs) of target messenger RNAs (Reinhart et al., Nature, 2000). As a founding member of the let-7 family, it is primarily recognized for its role as a potent tumor suppressor, where it negatively regulates several key oncogenes including RAS, MYC, and HMGA2 (Johnson et al., Cell, 2005; Sampson et al., Cancer Res, 2007). In various malignancies, such as lung and breast cancer, let-7a expression is frequently lost or significantly reduced, contributing to uncontrolled cell proliferation and metastasis (Takamizawa et al., Cancer Res, 2004). Beyond its role in oncology, let-7a is essential for proper developmental timing, stem cell differentiation, and the regulation of glucose metabolism (Boyerinas et al., Cancer Res, 2010). Therapeutic approaches currently under investigation involve the use of synthetic let-7a mimics to restore its function in cancer cells and inhibit tumor growth (Trang et al., Mol Ther, 2011). However, challenges remain regarding the efficient delivery of these RNA-based therapeutics and the potential for off-target effects or innate immune system activation (Ling et al., Nat Rev Drug Discov, 2013).

Other names
hsa-let-7a-5pMIRLET7Alet-7a-1let-7a-2let-7a-3Lethal-7a
02

Mechanism of action

Post-transcriptional gene silencing via seed-sequence-mediated binding to the 3' UTR of target mRNAs, leading to translational repression or mRNA cleavage (Bartel, Cell, 2004).

03

Biological functions

Post-transcriptional gene regulationCell differentiationTumor suppressionCell cycle regulationDevelopmental timing
04

Disease associations

CancerLung cancerBreast cancerColorectal cancerCardiovascular diseaseFibrosis
05

Safety considerations

Off-target gene silencingInnate immune response activation (TLR7/8)Delivery-related toxicity
06

Interacting drugs

let-7a mimic

1 more in the full profile.

07

Biomarkers

let-7a expression levelRAS protein levelHMGA2 expression level

Beyond the preview

Go deeper on microRNA let-7a (let-7a) (let-7a).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA let-7a (let-7a) (let-7a).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call